To detect the possible regulatory mechanism underlying KIF2A affecting the clinical features of osteosarcoma, we then used shRNA specifically targeted KIF2A to deplete the expression of KIF2A in two types of osteosarcoma cell lines, MG-63 and U2OS cell lines. This evidence concerns the gene KIF2A and osteosarcoma.